Strategic Initiative

Slingshot members are tracking this corporate initiative:

AstraZeneca (AZN) and Allergan (AGN) Complete Licensing Agreement for MEDI2070 Antibody Candidate in Mid-Stage Development for Crohn's Disease and Ulcerative Colitis

Source Link:: https://www.sec.gov/Archives/edgar/data/901832/000165495416004134/a3960p.htm

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies

Importance

High

Medium

Low

Impact on Stocks

AGN

100%

AZN

100%

SIGN ME UP
I want to vote! LOG ME IN
Now!

Slingshot Insights Explained

JOIN FOR FREE TODAY

Strategic Initiative Date

Announcement Date:

Nov 17, 2016

Projected Implementation:

Q1, 2017

Relevance Tracked Until:

Q1, 2019

Related Projects

Don’t see a project related to the strategic initiative you care about?

Related Keywords Licensing Agreement, Medi2070, Monoclonal Antibody, Product Candidate, Crohn's Disease, Ulcerative Colitis